Europe stocks open higher Stock Chart IconStock chart icon Stoxx 600 index. European stocks opened cautiously higher on Friday, with the Stoxx
Tag: Novo Nordisk A/S
Amgen scraps experimental weight loss pill, moves forward with injection
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen
Novo Nordisk earnings Q1 2024, Wegovy sales double
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson |
Morningstar likes these 7 stocks in Europe
Attractive returns and the breadth of opportunities are among the many reasons why investors have historically preferred investing in the U.S. to
These are the top 5 companies to work for in India, says LinkedIn
These are the 2024 top companies in India, according to LinkedIn. Deepak Sethi | E+ | Getty Images LinkedIn has released its
A top NVDA shareholder reveals his trigger for selling growth stocks
Nvidia shares have continued to soar this year, up more than 80%. But one of its top shareholders has revealed why they’ve
Amgen aims to enter weight loss drug market with a new approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen
How much people are willing to spend
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters
New funds target weight loss, Big Tech hype: Roundhill Investments
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. In health care,
Wegovy heart health approval won’t mean broad insurance coverage yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a
No More Posts Available.
No more pages to load.